Boucher & Muir Pty Ltd

Status: Registered
Australian Company Number: 000140474
Australian Business Number: 58000140474
Address: Level 1 134 Willoughby Rd Crows Nest NSW 2065 (business name: Bnm Group)
Registration date: September 24, 1954
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated


Boucher & Muir Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 1954-09-24 and was issued with the 000140474 ACN. Its Australian Business Number is 58000140474. Since 2014-08-22, the company is headquartered in NSW, post code 2065. The previous headquarters were located in NSW 2065 (from 2014-01-11 to 2014-08-22), NSW 2065 (from 2000-06-17 to 2014-01-11). Boucher & Muir Pty Ltd was registered for the GST on 2000-07-01. Boucher & Muir Pty Ltd has been using the Bnm Group trading name since 2008-12-23 (it needs to be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 4 trading names. The company has also used 1 business name, namely Bnm Group from 2015-08-04. The above data comes from the ABN database which was updated on 2015-09-11. found 1 trademark that mention this company. Trademark number 943001 was filed on 2003-02-10 and is categorised as "word" (application status: "registered, live").


Details for ABN 58000140474

Type: Australian Private Company

ABN Status

Status From To
Active May 11, 2000 current

Main Name

Name From To
Boucher & Muir Pty Ltd August 4, 2000 current
Boucher & Muir P/l May 11, 2000 August 4, 2000

Business Names

Name From To
Bnm Group August 4, 2015 current

Trading Names

Name From To
Bnm Group December 23, 2008 current
Boucher & Muir Pty Ltd June 20, 2006 current
Boucher & Muir Pty Ltd April 1, 2006 June 20, 2006
Goldshield Healthcare [australia] April 1, 2006 current

Main Location

Location From To
NSW 2065 August 22, 2014 current
NSW 2065 January 11, 2014 August 22, 2014
NSW 2065 June 17, 2000 January 11, 2014

Goods & Services Tax (GST)

Status From To
Registered July 1, 2000 current


Business names details

Bnm Group

Status registered
Registration date August 5, 2015
Renewal date September 24, 2017
Address for service of documents Level 1 134 Willoughby Rd Crows Nest NSW 2065
Principal place of business Level 1 134 Willoughby Rd Crows Nest NSW 2065
Debtor representative not applicable
Notified successor not applicable


Company Trademarks

Trademark number: 943001

General information:
Application date: February 10, 2003
Lodgement date: February 10, 2003
Registered date: February 10, 2003
Live or dead: Live
CPI status: Registered
Status: Registered/Protected
Mark code: Trade Mark
Trademark type: Word
Acceptance due date: May 29, 2003
Sealing due date: December 12, 2003
Registered from date: February 10, 2003
Sealing date: September 22, 2003
Renewal due date: February 10, 2023
Court orders: No
Revocation of the acceptance: No
Goods and services assistance: No
Lodgement type: Online
Descriptive: Optycin, Primacin
Examination report number: 1
Examination class count: 1
NICE class code: 5
NICE occ number: 1
NICE description text: Medicines
Applicant information:
Suburb name: North Sydney
Postcode: 2059
Australian state code: NSW
Country code: AU

Government contract data

Latest 2007 contracts

Date Description Contract ID Value
October 27, 2007 Drugs and Pharmaceutical Products CN42609 55 109.45

Find company


2016 © - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us:
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2015 (, and, ©Intellectual Property Government Open Data 2015, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.